A previous study has revealed that NRSN2 is highly expressed in osteosarcoma tissues and promotes cell proliferation via the dysregulation of PI3K/Akt/mTOR and Wnt/β‐catenin signaling pathways [18]. This evidence concerns the gene NRSN2 and osteosarcoma.